drugset / Trial / NCT02578602
MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
Phase 1
Completed
26 enrolled
University of Southern California
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This pilot clinical trial studies magnetic resonance imaging (MRI) with gadoxetate disodium in measuring tumors in patients with liver cancer. Diagnostic procedures, such as MRI with gadoxetate disodium, may help find and diagnose liver cancer and find out how far the disease has spread. It is not yet known whether MRI with gadoxetate disodium provides a more precise measurement of liver tumors than standard computed tomography (CT).
Timeline
- Start
- 2010-10
- Primary completion
- 2014-11
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadoxetate Disodium | Diagnostic / imaging agent | — | Intravenous |